High concentration biotherapeutic formulation and ultrafiltration: Part 1 pressure limits

scientific article

High concentration biotherapeutic formulation and ultrafiltration: Part 1 pressure limits is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/BTPR.2334
P8608Fatcat IDrelease_rkdoxwxuwjgibihgy4rfe4gqre
P698PubMed publication ID27452237

P2093author name stringYu Zou
Herb Lutz
Joshua Arias
P2860cites workDo clustering monoclonal antibody solutions really have a concentration dependence of viscosity?Q36621942
Biopharmaceutical formulations for pre-filled delivery devicesQ38090687
The role of amino acid sequence in the self-association of therapeutic monoclonal antibodies: insights from coarse-grained modelingQ38422315
Coarse-grained modeling of the self-association of therapeutic monoclonal antibodiesQ38424194
Hard quasispherical model for the viscosity of hemoglobin solutionsQ39163501
Structure-activity relationship for hydrophobic salts as viscosity-lowering excipients for concentrated solutions of monoclonal antibodiesQ39332318
Intrinsic fluorescence-based at situ soft sensor for monitoring monoclonal antibody aggregationQ40773419
Intermolecular Interactions and the Viscosity of Highly Concentrated Monoclonal Antibody SolutionsQ41127186
Understanding and modulating opalescence and viscosity in a monoclonal antibody formulationQ41962039
Weak interactions govern the viscosity of concentrated antibody solutions: high-throughput analysis using the diffusion interaction parameterQ42154434
High concentration formulation feasibility of human immunoglubulin G for subcutaneous administrationQ44263370
The influence of charge distribution on self-association and viscosity behavior of monoclonal antibody solutionsQ44321777
Both protein adsorption and aggregation contribute to shear yielding and viscosity increase in protein solutionsQ44796408
Reversible self-association of a concentrated monoclonal antibody solution mediated by Fab-Fab interaction that impacts solution viscosityQ46054883
Reversible self-association increases the viscosity of a concentrated monoclonal antibody in aqueous solutionQ46141707
Rheological and syringeability properties of highly concentrated human polyclonal immunoglobulin solutionsQ46839916
Electrostatic effects on protein partitioning in size-exclusion chromatography and membrane ultrafiltrationQ47291984
Effect of cell culture medium components on color of formulated monoclonal antibody drug substance.Q50875203
Viscosity analysis of the temperature dependence of the solution conformation of ovalbumin.Q52076692
Eine neue Bestimmung der MoleküldimensionenQ56555256
The effect of Brownian motion on the bulk stress in a suspension of spherical particlesQ56555260
P433issue1
P921main subjectultrafiltrationQ559573
P304page(s)113-124
P577publication date2016-07-25
P1433published inBiotechnology ProgressQ15753227
P1476titleHigh concentration biotherapeutic formulation and ultrafiltration: Part 1 pressure limits
P478volume33

Reverse relations

Q90448065Structure, heterogeneity and developability assessment of therapeutic antibodiescites workP2860

Search more.